Project Grant R35GM163633
- Federal Project Grant Award Summary Boston College received a $620,000 project grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on September 1, 2025, with a completion date of July 31, 2030. This award funds fundamental research into catalytic radical processes for stereoselective chemical synthesis, a field that leverages one-electron homolytic radical chemistry to complement traditional...
- Federal Project Grant Award Summary Boston College received a $325,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop a chemical synthesis platform for the scalable production of biologically significant polysaccharides. The award, effective from September 1, 2025, through August 31, 2026, supports research aimed at advancing living cationic ring-opening polymerization techniques...
- Federal Grant Award Summary Boston College received a $775,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025 through May 31, 2030. The award funds a five-year research initiative investigating evolutionary constraints on regulatory ribonucleic acid (RNA), with research activities to be conducted at the university's Chestnut Hill, Massachusetts campus. The research...
- Federal Grant Award Summary Boston University received a $437,036 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, with completion targeted for May 31, 2031. This five-year research initiative focuses on genomic enzymology to decipher bacterial membrane-associated glycan assembly, a critical area of investigation for understanding how bacteria synthesize...
- Federal Project Grant Award Summary Boston University Medical Campus received a $439,148 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 13, 2026, with completion targeted for January 31, 2031. The award funds a five-year research project investigating the fundamental mechanisms of mitochondrial deoxyribonucleic acid (DNA) packaging and gene expression regulation. The research...
- Federal Project Grant Award Summary The University of Massachusetts Boston received a $422,173 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025 through June 30, 2030. The award funds fundamental basic research investigating cellular signaling networks that control organism development and tissue patterning. The research employs the fruit fly Drosophila as a model...
- Federal Grant Award Summary Boston University received a $449,625 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 5, 2026, with a completion date of December 31, 2030. This award supports research aimed at advancing the targeted delivery of intracellular protein therapeutics through the development of next-generation virus-like particles (VLPs). The research leverages the...
- Federal Grant Award Summary Harvard College, through its Office For Sponsored Programs Division, received a $508,111 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through February 28, 2031. The award supports fundamental research investigating the molecular mechanisms and selectivity determinants of bacterial membrane proteins that mediate critical cellular...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Boston University $433,750 under the Biomedical Research and Research Training program (CFDA 93.859) on April 1, 2026, to support a five-year research initiative extending through February 28, 2031. The award funds the development of computational and network-based models designed to advance understanding of continuous cell states across multiple biological contexts. The research will integrate...
- Federal Project Grant Award Summary Trustees of Tufts College received a $256,616 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, with completion targeted for August 31, 2029. The award supports the development of a comprehensive graph theory toolbox designed to analyze genetic interaction networks and uncover redundant biological pathways. The research...
Boston College received a $641,700 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with an award date of August 1, 2026, and completion date of March 31, 2031. The grant supports the development of chemical-proteomic tools and methodologies to investigate cysteine modifications in proteins across distinct subcellular compartments. The research deliverables include advancement of chemoproteomic platforms that identify functional cysteines involved in critical protein functions such as nucleophilic catalysis, redox regulation, metal binding, and covalent liganding, with particular emphasis on spatial localization of analyses within mitochondrial and nuclear compartments. Over the five-year project period, the funded research will expand existing chemoproteomic capabilities by coupling proximity biotinylation methods with targeted analyses to investigate uncharacterized protein regulation mechanisms. Specific research objectives include mechanistic investigation of iron-sulfur cluster formation in mitochondria, evaluation of cysteine oxidation during growth-factor signaling proximal to the plasma membrane, and development of electrophilic modification platforms for cysteine regulation. These investigator-initiated research activities represent fundamental basic research designed to increase understanding of biological processes and establish foundations for advances in disease diagnosis, treatment, and prevention consistent with NIGMS's mission priorities.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $641.7k | 5/19/26 |